{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:45:20Z","timestamp":1770482720575,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.biomaterials.2008.10.035","type":"journal-article","created":{"date-parts":[[2008,11,23]],"date-time":"2008-11-23T04:20:13Z","timestamp":1227414013000},"page":"879-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-\u025b-caprolactone-based nanoparticles"],"prefix":"10.1016","volume":"30","author":[{"given":"H.F.","family":"Florindo","sequence":"first","affiliation":[]},{"given":"S.","family":"Pandit","sequence":"additional","affiliation":[]},{"given":"L.","family":"Lacerda","sequence":"additional","affiliation":[]},{"given":"L.M.D.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"H.O.","family":"Alpar","sequence":"additional","affiliation":[]},{"given":"A.J.","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2008.10.035_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.tvjl.2006.05.011","article-title":"Getting a grip on strangles: recent progress towards improved diagnostics and vaccines","volume":"173","author":"Waller","year":"2007","journal-title":"Vet J"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1939-1676.2005.tb02671.x","article-title":"Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles","volume":"19","author":"Sweeney","year":"2005","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.2042-3292.1996.tb01713.x","article-title":"Strangles: Streptococcus equi infection in horses","volume":"8","author":"Sweeney","year":"1996","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1286-4579(02)01565-4","article-title":"The molecular basis of Streptococcus equi infection and disease","volume":"4","author":"Harrington","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib5","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0264-410X(01)00488-1","article-title":"Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin","volume":"20","author":"Sheoran","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vaccine.2006.06.086","article-title":"N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model","volume":"25","author":"Amidi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib7","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","article-title":"Vaccine adjuvants revisited","volume":"25","author":"Aguilar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2004.12.026","article-title":"Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres","volume":"294","author":"Jaganathan","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib9","series-title":"Antigen delivery systems: immunological and technological issues","first-page":"207","article-title":"Mucosal immunisation with antigen-containing microparticles","author":"Almeida","year":"1997"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1211\/jpp.58.6.0002","article-title":"Particulate delivery systems for vaccines: what can we expect?","volume":"58","author":"Bramwell","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1163\/156856299X00892","article-title":"Intranasal immunization against influenza virus using polymeric particles","volume":"10","author":"Lemoine","year":"1999","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib13","first-page":"273","article-title":"Intranasal vaccines: forthcoming challenges","volume":"3","author":"Partidos","year":"2000","journal-title":"PSTT"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib14","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.vaccine.2006.01.011","article-title":"Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally","volume":"24","author":"Jaganathan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpb.2003.09.006","article-title":"Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice","volume":"57","author":"Vila","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2005.04.037","article-title":"Preparation of coated nanoparticles for a new mucosal vaccine delivery system","volume":"299","author":"Borges","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00726-007-0532-1","article-title":"Enhancement of intestinal absorption of macromolecules by spermine in rats","volume":"33","author":"Sugita","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib18","article-title":"Surfactants in vaccine adjuvants: description and perspectives","volume":"24S2","author":"Ascarateil","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib19","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.vaccine.2003.11.011","article-title":"Glycol chitosan improves the efficacy of intranasally administered replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpes virus 1","volume":"22","author":"Gogev","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib20","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1016\/j.vaccine.2008.05.074","article-title":"S. equi antigens adsorbed onto surface modified poly-caprolactone microspheres induce humoral and cellular specific immune responses","volume":"26","author":"Florindo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib21","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-1759(86)90351-0","article-title":"Measurement of human and mouse anti-tetanus antibodies and isotype analysis by ELISA","volume":"87","author":"Farzad","year":"1986","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0264-410X(98)00321-1","article-title":"MHC class I- and class II-restricted processing and presentation of microencapsulated antigens","volume":"17","author":"Ying","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/026520400405732","article-title":"Influence of various technological parameters on the preparation of spray-dried poly(epsilon-caprolactone) microparticles containing a model antigen","volume":"17","author":"Baras","year":"2000","journal-title":"J Microencapsul"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5173(99)00107-6","article-title":"Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification","volume":"184","author":"Lamprecht","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib27","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/iai.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijpharm.2007.02.008","article-title":"Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-co-glycolide) microparticle","volume":"338","author":"Lee","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0939-6411(00)00079-5","article-title":"Revisiting PLA\/PLGA microspheres: an analysis of their potential in parenteral vaccination","volume":"50","author":"Johansen","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(99)00109-X","article-title":"Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery","volume":"184","author":"Benoit","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymeth.2005.11.003","article-title":"Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems","volume":"38","author":"Singh","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib32","first-page":"198","article-title":"Identification of some physicochemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery","volume":"40","author":"Alpar","year":"1994","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0264-410X(02)00516-9","article-title":"Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant","volume":"21","author":"Isaka","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biomaterials.2008.10.035_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2006.04.007","article-title":"Microencapsulation of Streptococcus equi antigens in biodegradable microspheres and preliminary immunisation studies","volume":"64","author":"Azevedo","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib35","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1023\/A:1015832302605","article-title":"Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules","volume":"8","author":"Singh","year":"1991","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02786362","article-title":"Nasal lymphoid tissue, intranasal immunization and compartmentalization of the common mucosal immune system","volume":"16","author":"Wu","year":"1997","journal-title":"Immunol Res"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib38","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S0264-410X(98)00089-9","article-title":"Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal, intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines","volume":"16","author":"Eyles","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2008.10.035_bib39","series-title":"Topics in vaccine adjuvant research","first-page":"11","article-title":"Antigen processing and presentation in vivo","author":"Szakal","year":"2001"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961208008272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961208008272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:05:18Z","timestamp":1758899118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961208008272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0142961208008272"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2008.10.035","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-\u025b-caprolactone-based nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2008.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}